Congruence Therapeutics: Funding, Investors & Team (Sep 2026)
Congruence Therapeutics functions as a biotechnology firm that utilizes both computational and experimental methods in drug discovery for creating innovative small molecules aimed at treating conditions caused by protein misfolding.
Congruence Therapeutics has raised $104M across 3 funding rounds on record, the most recent an undisclosed round of $39.5M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Congruence Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Congruence Therapeutics Funding Rounds
Congruence Therapeutics raised $49.6M in a Series A announced in Feb 2022.
1.1 years later, a Series A of $15.0M was announced in Mar 2023.
3 years later, an undisclosed round of $39.5M was announced in Mar 2026.
Congruence Therapeutics Founders and Leadership Team
Contact details for the Congruence Therapeutics team: 1 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Congruence Therapeutics Funding Compared to Other Biotechnology Startups
Congruence Therapeutics' latest round of $39.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Congruence Therapeutics in Biotechnology and Montréal
Companies Similar to Congruence Therapeutics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Congruence Therapeutics Funding FAQs
What does Congruence Therapeutics do?
Congruence Therapeutics functions as a biotechnology firm that utilizes both computational and experimental methods in drug discovery for creating innovative small molecules aimed at treating conditions caused by protein misfolding.
How much funding has Congruence Therapeutics raised?
Congruence Therapeutics has raised $104M across 3 rounds on record. The most recent is an undisclosed round of $39.5M announced in Mar 2026.
When did Congruence Therapeutics last raise funding?
Congruence Therapeutics' most recent funding round on record is an undisclosed round of $39.5M, announced in Mar 2026.
Who founded Congruence Therapeutics?
FundedIQ lists Charles Grubsztajn (Founder), Michael Rock Goldsmith (Founder) at Congruence Therapeutics.
Who is the CEO of Congruence Therapeutics?
Clarissa Desjardins is listed as CEO at Congruence Therapeutics.
Where is Congruence Therapeutics headquartered?
Congruence Therapeutics is based in Montréal, Quebec, Canada.
How many employees does Congruence Therapeutics have?
Congruence Therapeutics is in the 11-50 employee band.
How does Congruence Therapeutics' funding compare to other Biotechnology startups?
Congruence Therapeutics' latest round of $39.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Congruence Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Congruence Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.